Prohibitin facilitates cellular senescence by recruiting specific corepressors to inhibit E2F target genes

Molecular and Cellular Biology

Volumn 26, Issue 11, 2006, Pages 4161-4171

  Rastogi, Shipra ^a   Joshi, Bharat ^a,b   Dasgupta, Piyali ^a   Morris, Mark ^a   Wright, Kenneth ^a   Chellappan, Srikumar ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; COMPLEMENTARY DNA; HISTONE H3; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROHIBITIN; SMALL INTERFERING RNA; SULFUR 35; TRANSCRIPTION FACTOR E2F; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL AGING; CELL GROWTH; CELL STRAIN MCF 7; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ISOTOPE LABELING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENESCENCE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

BETA-GALACTOSIDASE; CELL AGING; CELL LINE, TUMOR; CELL NUCLEUS; CHROMOSOMAL PROTEINS, NON-HISTONE; E2F TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HETEROCHROMATIN; HUMANS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN TRANSPORT; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC;

EID: 33646877911     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.02142-05     Document Type: Article

References (67)

1. Ait-Si-Ali, S., V. Guasconi, L. Fritsch, H. Yahi, R. Sekhri, I. Naguibneva, P. Robin, F. Gabon, A. Polesskaya, and A. Harel-Bellan. 2004. A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells. EMBO J. 23:605-615.
2. Alcorta, D. A., Y. Xiong, D. Phelps, G. Hannon, D. Beach, and J. C. Barrett. 1996. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA 93:13742-13747.
3. Berger, K. H., and M. P. Yaffe. 1998. Prohibitin family members interact genetically with mitochondrial inheritance components in Saccharomyces cerevisiae. Mol. Cell. Biol. 18:4043-4052.
4. Brehm, A., E. A. Miska, D. J. McCance, J. L. Reid, A. J. Bannister, and T. Kouzarides. 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597-601.
5. Campisi, J. 2001. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 11:827-31.
6. Chang, B. D., E. V. Broude, M. Dokmanovic, H. Zhu, A. Ruth, Y. Xuan, E. S. Kandel, E. Lausch, K. Christov, and I. B. Roninson. 1999. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res. 59:3761-3767.
7. Chang, B. D., M. E. Swift, M. Shen, J. Fang, E. V. Broude, and I. B. Roninson. 2002. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc. Natl. Acad. Sci. USA 99:389-394.
8. Cheutin, T., A. J. McNairn, T. Jenuwein, D. M. Gilbert, P. B. Singh, and T. Misteli. 2003. Maintenance of stable heterochromatin domains by dynamic HP1 binding. Science 299:721-725.
9. Coates, P. J., D. J. Jamieson, K. Smart, A. R. Prescott, and P. A. Hall. 1997. The prohibitin family of mitochondrial proteins regulate replicative lifespan. Curr. Biol. 7:607-610.
10. Coates, P. J., R. Nenutil, A. McGregor, S. M. Picksley, D. H. Crouch, P. A. Hall, and E. G. Wright. 2001. Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence. Exp. Cell Res. 265:262-273.
11. Dell'Orco, R. T., J. K. McClung, E. R. Jupe, and X. T. Liu. 1996. Prohibitin and the senescent phenotype. Exp. Gerontol. 31:245-252.
12. Dimri, G. P., E. Hara, and J. Campisi. 1994. Regulation of two E2F-related genes in presenescent and senescent human fibroblasts. J. Biol. Chem. 269: 16180-16186.
13. Dimri, G. P., X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E. E. Medrano, M. Linskens, I. Rubelj, O. Pereira-Smith, et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92:9363-9367.
14. Dimri, G. P., A. Testori, M. Acosta, and J. Campisi. 1996. Replicative senescence, aging and growth-regulatory transcription factors. Biol. Signals 5:154-162.
15. Drayton, S., and G. Peters. 2002. Immortalisation and transformation revisited. Curr. Opin. Genet. Dev. 12:98-104.
16. Eissenberg, J. C., and S. C. Elgin. 2000. The HP1 protein family: getting a grip on chromatin. Curr. Opin. Genet. Dev. 10:204-210.
17. Elmore, L. W., C. W. Rehder, X. Di, P. A. McChesney, C. K. Jackson-Cook, D. A. Gewirtz, and S. E. Holt. 2002. Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction. J. Biol. Chem. 277:35509-35515.
18. Fuks, F. 2005. DNA methylation and histone modifications: teaming up to silence genes. Curr. Opin. Genet. Dev. 15:490-495.
19. Fusaro, G., P. Dasgupta, S. Rastogi, B. Joshi, and S. Chellappan. 2003. Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J. Biol. Chem. 278:47853-47861.
20. Hayflick, L., and P. S. Moorhead. 1961. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25:585-621.
21. Ikonen, E., K. Fiedler, R. G. Parton, and K. Simons. 1995. Prohibitin, an antiproliferative protein, is localized to mitochondria. FEBS Lett. 358:273-277.
22. Joshi, B., D. Ko, D. Ordonez-Ercan, and S. P. Chellappan. 2003. A putative coiled-coil domain of prohibitin is sufficient to repress E2F1-mediated transcription and induce apoptosis. Biochem. Biophys. Res. Commun. 312:459-466.
23. Jupe, E. R., X. T. Liu, J. L. Kiehlbauch, J. K. McClung, and R. T. Dell'Orco. 1995. Prohibitin antiproliferative activity and lack of heterozygosity in immortalized cell lines. Exp. Cell Res. 218:577-580.
24. Jupe, E. R., X. T. Liu, J. L. Kiehlbauch, J. K. McClung, and R. T. Dell'Orco. 1996. Prohibitin in breast cancer cell lines: loss of antiproliferative activity is linked to 3′ untranslated region mutations. Cell Growth Differ. 7:871-878.
25. Kamijo, T., F. Zindy, M. F. Roussel, D. E. Quelle, J. R. Downing, R. A. Ashmun, G. Grosveld, and C. J. Sherr. 1997. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91:649-659.
26. Kolonin, M. G., P. K. Saha, L. Chan, R. Pasqualini, and W. Arap. 2004. Reversal of obesity by targeted ablation of adipose tissue. Nat. Med. 10:625-632.
27. Kwak, I. H., H. S. Kim, O. R. Choi, M. S. Ryu, and I. K. Lim. 2004. Nuclear accumulation of globular actin as a cellular senescence marker. Cancer Res. 64:572-580.
28. Li, Y., D. A. Kirschmann, and L. L. Wallrath. 2002. Does heterochromatin protein 1 always follow code? Proc. Natl. Acad. Sci. USA 99(Suppl. 4): 16462-16469.
29. Liu, X. T., C. A. Stewart, R. L. King, D. A. Danner, R. T. Dell'Orco, and J. K. McClung. 1994. Prohibitin expression during cellular senescence of human diploid fibroblasts. Biochem. Biophys. Res. Commun. 201:409-414.
30. -ΔΔCT method. Methods 25:402-408.
31. Lowe, S. W., and C. J. Sherr. 2003. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr. Opin. Genet. Dev. 13:77-83.
32. Luo, R. X., A. A. Postigo, and D. C. Dean. 1998. Rb interacts with histone deacetylase to repress transcription. Cell 92:463-473.
33. Magnaghi-Jaulin, L., R. Groisman, I. Naguibneva, P. Robin, S. Lorain, J. P. Le Villain, F. Troalen, D. Trouche, and A. Harel-Bellan. 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601-605.
34. McClung, J. K., E. R. Jupe, X. T. Liu, and R. T. Dell'Orco. 1995. Prohibitin: potential role in senescence, development, and tumor suppression. Exp. Gerontol. 30:99-124.
35. Meloni, A. R., E. J. Smith, and J. R. Nevins. 1999. A mechanism for Rb/p130-mediated transcription repression involving recruitment of the CtBP corepressor. Proc. Natl. Acad. Sci. USA 96:9574-9579.
36. Narita, M., and S. W. Lowe. 2004. Executing cell senescence. Cell Cycle 3:244-246.
37. Narita, M., S. Nunez, E. Heard, A. W. Lin, S. A. Hearn, D. L. Spector, G. J. Hannon, and S. W. Lowe. 2003. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113:703-716.
38. Nielsen, A. L., M. Oulad-Abdelghani, J. A. Ortiz, E. Remboutsika, P. Chambon, and R. Losson. 2001. Heterochromatin formation in mammalian cells: interaction between histones and HP1 proteins. Mol. Cell 7:729-739.
39. Nielsen, S. J., R. Schneider, U. M. Bauer, A. J. Bannister, A. Morrison, D. O'Carroll, R. Firestein, M. Cleary, T. Jenuwein, R. E. Herrera, and T. Kouzarides. 2001. Rb targets histone H3 methylation and HP1 to promoters. Nature 412:561-565.
40. Nuell, M. J., D. A. Stewart, L. Walker, V. Friedman, C. M. Wood, G. A. Owens, J. R. Smith, E. L. Schneider, R. Dell'Orco, C. K. Lumpkin, et al. 1991. Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells. Mol. Cell. Biol. 11: 1372-1381.
41. Pandita, T. K., and J. L. Roti Roti. 2003. Role of telomerase in radiocurability (review). Oncol. Rep. 10:263-270.
42. Peters, A. H., D. O'Carroll, H. Scherthan, K. Mechtler, S. Sauer, C. Schofer, K. Weipoltshammer, M. Pagani, M. Lachner, A. Kohlmaier, S. Opravil, M. Doyle, M. Sibilia, and T. Jenuwein. 2001. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107:323-337.
43. 0-arrested cells. Mech. Ageing Dev. 123:287-295.
44. Rajalingam, K., C. Wunder, V. Brinkmann, Y. Churin, M. Hekman, C. Sievers, U. R. Rapp, and T. Rudel. 2005. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Nat. Cell Biol. 7:837-843.
45. Ramirez, R. D., C. P. Morales, B. S. Herbert, J. M. Rohde, C. Passons, J. W. Shay, and W. E. Wright. 2001. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev. 15: 398-403.
46. Rebbaa, A., X. Zheng, P. M. Chou, and B. L. Mirkin. 2003. Caspase inhibition switches doxorubicin-induced apoptosis to senescence. Oncogene 22: 2805-2811.
47. Roskams, A. J., V. Friedman, C. M. Wood, L. Walker, G. A. Owens, D. A. Stewart, M. S. Altus, D. B. Danner, X. T. Liu, and J. K. McClung. 1993. Cell cycle activity and expression of prohibitin mRNA. J. Cell. Physiol. 157:289-295.
48. Ross, J. F., X. Liu, and B. D. Dynlacht. 1999. Mechanism of transcriptional repression of E2F by the retinoblastoma tumor suppressor protein. Mol. Cell 3:195-205.
49. Sage, J., A. L. Miller, P. A. Perez-Mancera, J. M. Wysocki, and T. Jacks. 2003. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424:223-228.
50. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
51. Sato, T., H. Saito, J. Swensen, A. Olifant, C. Wood, D. Danner, T. Sakamoto, K. Takita, F. Kasumi, Y. Miki, et al. 1992. The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. Cancer Res. 52:1643-1646.
52. Shay, J. W., and I. B. Roninson. 2004. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23:2919-2933.
53. Shelton, D. N., E. Chang, P. S. Whittier, D. Choi, and W. D. Funk. 1999. Microarray analysis of replicative senescence. Curr. Biol. 9:939-945.
54. Sherr, C. J. 1998. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12:2984-2991.
55. Sherr, C. J., and R. A. DePinho. 2000. Cellular senescence: mitotic clock or culture shock? Cell 102:407-410.
56. Steglich, G., W. Neupert, and T. Langer. 1999. Prohibitins regulate membrane protein degradation by the m-AAA protease in mitochondria. Mol. Cell. Biol. 19:3435-3442.
57. Stein, G. H., L. F. Drullinger, A. Soulard, and V. Dulic. 1999. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol. Cell. Biol. 19: 2109-2117.
58. Strober, B. E., J. L. Dunaief, Guha, and S. P. Goff. 1996. Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family of proteins. Mol. Cell. Biol. 16:1576-1583.
59. te Poele, R. H., A. L. Okorokov, L. Jardine, J. Cummings, and S. P. Joel. 2002. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 62:1876-1883.
60. Trimarchi, J. M., and J. A. Lees. 2002. Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell Biol. 3:11-20.
61. Vandel, L., E. Nicolas, O. Vaute, R. Ferreira, S. Ait-Si-Ali, and D. Trouche. 2001. Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase. Mol. Cell. Biol. 21:6484-6494.
62. Wang, S., G. Fusaro, J. Padmanabhan, and S. P. Chellappan. 2002. Prohibitin colocalizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression. Oncogene 21:8388-8396.
63. Wang, S., N. Nath, M. Adlam, and S. Chellappan. 1999. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene 18:3501-3510.
64. Wang, S., N. Nath, G. Fusaro, and S. Chellappan. 1999. Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals. Mol. Cell. Biol. 19:7447-7460.
65. Wang, S., B. Zhang, and D. V. Faller. 2002. Prohibitin requires Brg-1 and Brm for the repression of E2F and cell growth. EMBO J. 21:3019-3028.
66. 1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101:79-89.
67. Zheng, X., P. M. Chou, B. L. Mirkin, and A. Rebbaa. 2004. Senescence-initiated reversal of drug resistance: specific role of cathepsin L. Cancer Res. 64:1773-1780.